Completed PHASE1 INTERVENTIONAL 1-arm NCT00572611

Human Mass Balance Study With Bilastine

A Phase I Study to Investigate the Absorption, Metabolism and Excretion of [14C]-Bilastine Following Oral Administration to Healthy Volunteers

Sponsor: Charles River Clinical Services Edinburgh Ltd and CR Laboratories Preclinical Services Ltd

Conditions Healthy

Interventions [14C]-bilastine

Updated 5 times since 2017 Last updated: Sep 25, 2012 Started: Nov 30, 2007 Primary completion: Dec 31, 2007 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Charles River Clinical Services Edinburgh Ltd and CR Laboratories Preclinical Services Ltd and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Charles River Clinical Services Edinburgh Ltd and CR Laboratories Preclinical Services Ltd
Faes Farma, S.A.
MDS Pharma Services Switzerland AG

Data source: Faes Farma, S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Riccarton, United Kingdom